Analytical Test Method Validation Report Template

1. Purpose
The purpose of this Validation Summary Report is to summarize the finding of the validation of test method
Determination of , following Validation Protocol ..
2. Scope/Test Method Description
Optional: may be restated from the protocol.
3.

Background
Optional: may be restated from the protocol.

4. Strategy
Optional: may be restated from the protocol.
5.

Procedures
Include synopsis of procedure for execution of validation of each characteristic. Include acceptance criteria for
each characteristic.
5.1. Accuracy
Accuracy should be reported as percent recovery of the known added amount or as the difference
between the mean and the accepted true value together with the confidence intervals.
The concentration ranges used should be stated, as should the number of replicates tested.
In the table, the terms concentration 1, 2, and 3 should be replaced with the actual concentrations used
in the experiments. Additional rows may be added if more concentrations were tested.
Table: % Recovery & Difference between Mean and Accepted Value
Analyte
Level

Actual
Concentration

Individual %
Recovery

Mean %
Recovery

P/F

% RSD

P/F

Level 1
Acceptance Criteria

Level 2
Acceptance Criteria

Level 3
Acceptance Criteria

5.2. Precision
5.2.1. Method Precision
Describe the experiments to determine repeatability. Appropriate table shells for this section are
provided below. This table assumes 3 replicate sample preparations at 3 concentrations and assumes

Page1of6

quantitation of the results. In cases where visual inspection is used, replicate chromatograms may be
used in place of tables.
Analysis Repeatability Using Different Concentrations
Analyte
Level
Concentration
Level 1

Amount of
Analyte
Replicate 1
Replicate 2
Replicate 3
Acceptance Criteria

Concentration
Level 2

Replicate 1
Replicate 2
Replicate 3
Acceptance Criteria

Concentration
Level 3

Replicate 1
Replicate 2
Replicate 3
Acceptance Criteria

Measured
parameter

Mean

% RSD

P/F

Repeatability using Multiple Determinations at the Test Concentration

Determination

Measured parameter

Replicate 1
Replicate 2
Replicate 3
Replicate 4
Replicate 5
Replicate 6
Mean
% RSD
Acceptance Criteria
P/F

5.2.2.Intermediate Precision
Depending on the nature of the analysis and results visual inspection or quantitative data, either
the appropriate figures or table should be included in this section. The table below shows a sample
layout for reporting intermediate precision where quantitative data is obtained.

Page2of6

Determination

Analyst 1 /Lab 1/Day 1

Analyst 2 /Lab2/Day 2

Sample 1
Sample 2
Sample 3
Sample 4
Sample 5
Sample 6
Mean (N=6)
% RSD (N=12)
Acceptance Criteria (N=12)
P/F

5.3. Specificity
Provide representative figures of a placebo, representative sample, and a stressed sample.
Figure 1: Placebo Sample
Figure 2: Representative Sample
Figure 3: Stressed Sample
Discuss the results of the specificity experiments. If method specificity is not demonstrated, describe
how additional test methods in combination with this test method are used to provide the appropriate
specificity.
Stress Condition
Heat
Oxidation
Humidity
Light
Acid
Base

Purity Angle

Purity Threshold

% Degradation

5.4. Linearity and Range

Define the range of concentrations chosen in both concentration units and as % of the test
concentration in the method. Briefly describe how the standard solutions were prepared.
State statistical analysis was used and specific tests that were performed. Discuss the scatter in the
data points around the linear regression line, i.e. whether the scatter appears to be random or nonrandom, and the implications of the data scatter pattern.
Provide a graph of the linearity data showing the individual data points and the regression line. Display
the regression equation on the graph or include as a sentence in the final report.
Figure: Linearity Graph (The axes on this graph should be labeled, including units)
State the range over which the assay was validated. In the table below, the terms concentration 1, 2, 3,
4, and 5 should be replaced with the actual concentrations used in the experiments. Additional rows
may be added if more samples were tested.

Page3of6

Level
Concentration Level relative nominal working
standard in %

Area
Actual Concentration

Concentration 1
Concentration 2
Concentration 3
Concentration 4
Concentration 5
Slope
y-intercept
Correlation Coefficient Acceptance Criteria r 0.XXX

P/F

5.5. Limit of Detection

Provide a figure showing the detection limit for the analyte.
Figure: Representative Sample Showing <Name of Analyte> at the Limit of Detection
Provides a visual statement of this limit and may represent one of the calibration curves. The data used
to calculate the actual level is captured in the table below.
Replicate
1
2
3
Acceptance Criteria
Pass/Fail

Anlyte Peak Area

Analyte S/N

3 for each replicate

5.6. Limit of Quanititation

State how the limit of quantitation is to be established visual inspection, signal-to-noise ratio or
standard deviation of the slope and response factor, and provide the relevant supporting data. If the
visual detection method is used, provide the values associated with the terms acceptable accuracy and
precision.
Figure: Representative Sample Showing <Name of Analyte> at the Limit of Quantitation
This figure should be clearly labeled to enable a reviewer to locate the peak(s) for the analyte(s) of
interest.
Signal-to-Noise ratio applicable where the data is quantitatively assessed.
Replicate
Determination
1
2
3
4
5
6
Mean
% RSD
Acceptance
Criteria
Pass/Fail

Analyte
Peak Area

Analyte
S/N

% RSD XX.0%

10 for each replicate

Page4of6

5.7. Robustness:
Standard Solution Stability
Time

2 8 C

Room Temperature
% of Analyte

% Difference

P/F

% of Analyte

% Difference

P/F

Day 0
Day x
Day Y
Day Z
Sample Solution Stability
Time

2 8 C

Room Temperature
% of Analyte

% Difference

P/F

% of Analyte

% Difference

P/F

Day 0
Day x
Day Y
Day Z
Method Parameter

Test methods Parameter

%RSD (area)

RRT

Injection Volume (Nominal)

Injection Volume 1
Injection Volume 2
Mobil Phase (Nominal)
Mobil Phase 1
Mobil Phase 2
Column Temp. (Nominal)
Column Temp. 1
Column Temp. 2
Detector Wavelength (Nominal)
Detector Wavelength 1
Detector Wavelength 2
Sample Extraction Time
(Nominal)
Sample Extraction Time 1
Sample Extraction Time 2
Sampling Time (Nominal)
Sampling Time 1
Sampling Time 2
Flow Rate (Nominal)
Flow Rate 1
Flow Rate 2
Column Lot 1
Column Lot 2
Column Lot 3

Page5of6

6. Deviations from Protocol

Include in this section: No deviations from validation protocol or list the deviations and reasons for those
deviations. State the impact of the deviation or variance on the protocol. State the impact of the variation or
deviation on the ability of the experiment to be suitable to validation.
7. Conclusion
Summarize the results of the Validation Study and conclude whether or not the Test Method is appropriate for
its intended use base on the validation results given in this report and the acceptance criteria set forth in the
Validation Protocol.
8. Recommendations
Indicate any changes that need to be made to the Test Method before it should be approved. These changes
should be a result of the robustness testing outcome and may include modifying or supplementing the System
Suitability section of the Test Method and/or adding caution statements about requirements for analyst control
of experimental parameters.
9. Attachments
Calibrated equipment list, signature log of executors, copies of pertinent training records, data tables,
chromatograms or printouts from equipment, figures as defined by results presentation and appropriate
notebook references or pages.

Page6of6